Cargando…
A meta-analysis of the efficacy of allopurinol in reducing the incidence of myocardial infarction following coronary artery bypass grafting
BACKGROUND: The xanthine oxidase inhibitor allopurinol that is commonly used to treat gout, has been suggested to have pleiotropic effects that are likely to reduce the incidence of myocardial infarction (MI) in at risk individuals. The aim of this meta-analysis was to assess the efficacy of allopur...
Autores principales: | Singh, Tejas P., Skalina, Tristan, Nour, Daniel, Murali, Aarya, Morrison, Sean, Moxon, Joseph V., Golledge, Jonathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6042232/ https://www.ncbi.nlm.nih.gov/pubmed/29996770 http://dx.doi.org/10.1186/s12872-018-0881-6 |
Ejemplares similares
-
Association of Computed Tomographic Leg Muscle Characteristics With Lower Limb and Cardiovascular Events in Patients With Peripheral Artery Disease
por: Morris, Dylan R., et al.
Publicado: (2018) -
Effects of allopurinol and vitamin E on renal function in patients with cardiac coronary artery bypass grafts
por: Nouri-Majalan, Nader, et al.
Publicado: (2009) -
Pregnancy after myocardial infarction and coronary artery bypass grafting – is it safe?
por: Janion-Sadowska, Agnieszka, et al.
Publicado: (2014) -
Posttraumatic stress disorder after myocardial infarction and coronary artery bypass grafting
por: Singh, Amitoj, et al.
Publicado: (2017) -
Myocardial inflammation, injury and infarction during on-pump coronary artery bypass graft surgery
por: Alam, Shirjel R., et al.
Publicado: (2017)